Educational Media Interventions for Cancer
(ADELANTE Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
Research shows that audiovisual programs can help cancer patients understand their disease better, reduce anxiety, and improve communication with healthcare staff. Additionally, many patients find video-based information helpful and report learning new information from it.
12345The studies reviewed did not report any safety concerns related to the use of audiovisual programs for educating cancer patients and their families. These programs were found to help reduce anxiety and improve understanding of cancer and its treatments.
35678The Audiovisual Intervention for Cancer Education is unique because it uses video-based educational materials to improve patients' understanding and confidence about cancer treatments, such as radiation therapy. Unlike traditional treatments that focus solely on medical procedures, this intervention aims to reduce anxiety and enhance communication by providing accessible information through engaging audiovisual content.
3591011Eligibility Criteria
This trial is for Latinx Spanish-speaking individuals with a confirmed diagnosis of non-metastatic breast or prostate cancer. They must have a Karnofsky performance status of 70 or above, indicating they are able to care for themselves. Women who can bear children need pregnancy tests as per guidelines. Participants should be planning to receive or currently undergoing curative radiation therapy and must consult using a certified interpreter.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Radiation Therapy Education
Participants receive educational material (either written brochures or audiovisual intervention) to prepare for radiation therapy
Radiation Therapy
Participants undergo radiation therapy for breast or prostate cancer
Follow-up
Participants are monitored for safety and effectiveness after treatment, including clinical trial enrollment and perceptivity
Long-term Follow-up
Participants' medical records are reviewed to ascertain subsequent cancer clinical trial enrollment